ScoreWhy is Neuland Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 16.00%
2
Company has a Debt to Equity ratio (avg) of 0.07 times
3
Healthy long term growth as Operating profit has grown by an annual rate 35.13%
4
With a growth in Net Profit of 424.21%, the company declared Very Positive results in Mar 26
- OPERATING PROFIT TO INTEREST(Q) Highest at 42.63 times
- CASH AND CASH EQUIVALENTS(HY) Highest at Rs 354.96 cr
- NET SALES(Q) Highest at Rs 776.25 cr
5
High Institutional Holdings at 36.3%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 0.69% over the previous quarter.
6
Consistent Returns over the last 3 years
- Along with generating 49.29% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Neuland Labs. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Neuland Labs. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Neuland Labs.
49.29%
1.11
44.51%
Sensex
-7.23%
-0.56
13.01%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.64%
EBIT Growth (5y)
35.13%
EBIT to Interest (avg)
20.70
Debt to EBITDA (avg)
0.76
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.97
Tax Ratio
25.56%
Dividend Payout Ratio
5.95%
Pledged Shares
2.29%
Institutional Holding
36.30%
ROCE (avg)
20.13%
ROE (avg)
16.00%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
58
Industry P/E
35
Price to Book Value
11.35
EV to EBIT
43.95
EV to EBITDA
36.93
EV to Capital Employed
11.65
EV to Sales
10.49
PEG Ratio
0.71
Dividend Yield
0.07%
ROCE (Latest)
26.51%
ROE (Latest)
19.42%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend37What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 42.63 times
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 354.96 cr
NET SALES(Q)
Highest at Rs 776.25 cr
PBDIT(Q)
Highest at Rs 307.33 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 39.59%
PBT LESS OI(Q)
Highest at Rs 275.03 cr.
PAT(Q)
Highest at Rs 212.67 cr.
EPS(Q)
Highest at Rs 164.86
-9What is not working for the Company
INTEREST(Latest six months)
At Rs 14.00 cr has Grown at 40.70%
Loading Valuation Snapshot...
Here's what is working for Neuland Labs.
Net Sales - Quarterly
At Rs 776.25 cr has Grown at 97.1% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 393.77 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 275.03 cr has Grown at 410.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 53.91 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 212.67 cr has Grown at 374.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 44.78 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 42.63 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales - Quarterly
Highest at Rs 776.25 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 307.33 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 39.59%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 275.03 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 212.67 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 164.86
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 354.96 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Neuland Labs.
Interest - Latest six months
At Rs 14.00 cr has Grown at 40.70%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Non Operating Income - Quarterly
Highest at Rs 12.46 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
